Get the Weekly Intelligence Brief — top committee picks every Sunday.

HIMS vs MANE

Hims & Hers Health vs Veradermics, Incorporated — AI-powered side-by-side comparison
HIMS
Hims & Hers Health
52
Watch
VS
MANE
Veradermics, Incorporated
65
Buy
MetricHIMSMANE
AI Score 52 65
Price $29.80 $102.53
P/E Ratio -52.05× -47.83×
ROE 23.7% 57.8%
Revenue Growth YoY
Gross Margin 64.7% 0.0%
Debt / Equity 4.77× 0.00×
Dividend Yield 0.0% 0.0%
RSI (14) 55.0 40.2
Beta 2.415 1.3492
Expected Upside +0.3% +13.6%

AI Committee View

Current Innellis committee reasoning for HIMS versus MANE.
MANE leads by 13 points.

MANE scores 65/100 (Buy) versus HIMS at 52/100 (Watch).

HIMS Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case. Value Analyst remains cautious — price-to-book of 13.7x prices in significant intangible value. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Revenue growing 32.8% YoY -- genuine top-line momentum — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • Price-to-book of 13.7x prices in significant intangible value — Value
  • ROE of only -2.5% -- cheap may mean cheap for a reason — Value
  • Debt-to-equity of 1.80 adds balance-sheet risk to the value case — Value
MANE Committee View
80% agreement
5 analysts

The primary driver is news sentiment is positive (+0.50 across 2 articles, 14d). The main limiting factor is rsi at 29 is in oversold territory (could mean either capitulation or a bounce setup). The committee is constructive but not yet at full conviction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
  • Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
Bear Case
  • RSI at 29 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
  • MACD histogram negative -- bearish momentum — Technical
  • Price trading below the lower Bollinger Band -- stretched to the downside — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
HIMS Full Analysis MANE Full Analysis